PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10134603

New technologies for laboratory productivity.

P Lapekas
View original source ↗Export metadata ↓

Abstract

The laboratory at St. Joseph Hospital in Kirkwood, MO was experiencing serious inefficiency problems and worker frustration because of its aging wet reagent clinical chemistry analyzers. The hospital replaced the three machines with two complementary Kodak analyzers as a part of a dry slide purchase/equipment lease program and implemented a laboratory information system that interfaces the analyzers with the hospital information system. Among other benefits, test results availability has improved 30%, worker training has gone from two weeks to two to three days and maintenance problems have been eliminated.

Explore related subjects

AutoanalysisClinical Laboratory Information SystemsCommerceContract ServicesCost SavingsDecision Making, OrganizationalEfficiency, OrganizationalHospital Bed Capacity, 300 to 499Laboratories, HospitalMissouriJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Lapekas. 1994. New technologies for laboratory productivity.. https://pubmed.ncbi.nlm.nih.gov/10134603/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Agilent 2100 bioanalyzer for restriction fragment length polymorphism analysis of the Campylobacter jejuni flagellin gene.

The Agilent 2100 bioanalyzer (Agilent Technologies, Palo Alto, Calif.) utilizes capillary electrophoresis on a microchip device (LabChip 7500; Caliper Technologies, Mountain View, Calif.) that is capable of rapidly sizing small DNA fragments. To determine whether the system could replace conventional restriction fragment length polymorphism (RFLP) typing by agarose gel electrophoresis, we compared the analyzer with conventional flagellin RFLP for typing Campylobacter jejuni. Ninety-seven isolates representing 46 Fla types were initially analyzed. Correct Fla types were detected in 59% of the isolates. The major problem with the system was in resolving samples containing multiple DNA fragments differing from 8 to 20 bp. Overall, the bioanalyzer has the potential to replace conventional RFLP analysis by gel electrophoresis, but improvements in the chip separation are needed.

Autoanalysis↗
PubMed2001

Long-term evaluation of electrospray ionization mass spectrometric analysis of glycated hemoglobin.

BACKGROUND: Electrospray ionization mass spectrometry (ESIMS) has been successfully applied to the identification of hemoglobin (Hb) variants and the presence of glucose adducts (mass difference of 162 Da) on the separate Hb alpha and beta chains. To establish the potential of ESIMS as a routine and/or a reference method for the quantification of glycohemoglobin (HbA1c), we carried out a detailed evaluation over a 4-month period in a routine laboratory environment. METHODS: We optimized a procedure using ESIMS suitable for the routine quantitative analysis of HbA1c. We determined reliability and reproducibility over 4 months and assessed the potential for automated sample injection. We then compared values of 1022 blood samples from diabetic patients with a routine HPLC-based ion-exchange procedure (HA-8140; Menarini). RESULTS: Results of HbA1c measurement by ESIMS were available within 3 min. The analytical imprecision (CV) was 1.6-5.0% for both manual and automated injections. Data collection over the m/z 980-1400 range confirmed lower glycation of the alpha chain relative to the beta chain (0.66:1). Only one glycation was observed per globin chain. The overall glycohemoglobin (i.e., the average of alpha- and beta-chain glycations) measured by ESIMS (x) on 1022 blood samples was lower than by HPLC (y): y = 1.0432x + 0.4815. However, the ss-chain glycation measured by ESIMS was up to 20% higher than the value measured by ion-exchange HPLC and showed a close conformity, particularly at 5-10% HbA1c, with the ion-exchange Diabetes Control and Complications Trial (DCCT)-corrected and the United Kingdom National External Quality Assessment Scheme DCCT mean return values. CONCLUSIONS: ESIMS provides a precise measurement of HbA1c and, in particular, glycation of the beta chain. The method is robust and could be proposed as a procedure to substantiate HbA1c measurement and/or calibration.

Autoanalysis↗